Thilo Kober

1.3k total citations · 1 hit paper
10 papers, 940 citations indexed

About

Thilo Kober is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Statistics, Probability and Uncertainty. According to data from OpenAlex, Thilo Kober has authored 10 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Statistics, Probability and Uncertainty. Recurrent topics in Thilo Kober's work include Lymphoma Diagnosis and Treatment (6 papers), Clinical practice guidelines implementation (3 papers) and Meta-analysis and systematic reviews (3 papers). Thilo Kober is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Clinical practice guidelines implementation (3 papers) and Meta-analysis and systematic reviews (3 papers). Thilo Kober collaborates with scholars based in Germany, United Kingdom and Switzerland. Thilo Kober's co-authors include David Moher, Kenneth F. Schulz, Larissa Shamseer, Douglas G. Altman, Sofia Dias, Lucy Turner, Amy C. Plint, Laura Weeks, Sven Trelle and Julia Bohlius and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cochrane Database of Systematic Reviews.

In The Last Decade

Thilo Kober

9 papers receiving 927 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals

2012 531 citations Lucy Turner, Larissa Shamseer et al. Cochrane Database of Systematic Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thilo Kober Germany	6	333	267	248	182	179	10	940
Vibeke Strand United States	13	272 0.8×	82 0.3×	31 0.1×	271 1.5×	127 0.7×	14	2.2k
David Phillippo United Kingdom	16	82 0.2×	133 0.5×	118 0.5×	57 0.3×	81 0.5×	29	1.1k
Arco C. Verhoeven Netherlands	19	321 1.0×	134 0.5×	25 0.1×	356 2.0×	86 0.5×	27	3.0k
G Kraag Canada	18	180 0.5×	91 0.3×	22 0.1×	200 1.1×	121 0.7×	31	1.9k
James K. Liu United States	23	154 0.5×	55 0.2×	107 0.4×	91 0.5×	287 1.6×	101	1.6k
J. W. P. F. Kardaun Netherlands	18	95 0.3×	47 0.2×	36 0.1×	54 0.3×	118 0.7×	37	1.1k
Marieke Voshaar Netherlands	20	255 0.8×	80 0.3×	11 0.0×	264 1.5×	122 0.7×	46	2.1k
Evan Kantor United States	10	166 0.5×	86 0.3×	27 0.1×	42 0.2×	77 0.4×	19	796
J. Michael Woolley United States	21	132 0.4×	82 0.3×	22 0.1×	32 0.2×	93 0.5×	42	1.5k
Jolanda J. Luime Netherlands	28	170 0.5×	54 0.2×	13 0.1×	149 0.8×	65 0.4×	100	2.3k

Countries citing papers authored by Thilo Kober

Since Specialization

Citations

This map shows the geographic impact of Thilo Kober's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thilo Kober with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thilo Kober more than expected).

Fields of papers citing papers by Thilo Kober

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thilo Kober. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thilo Kober. The network helps show where Thilo Kober may publish in the future.

Co-authorship network of co-authors of Thilo Kober

This figure shows the co-authorship network connecting the top 25 collaborators of Thilo Kober. A scholar is included among the top collaborators of Thilo Kober based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thilo Kober. Thilo Kober is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Turner, Lucy, Larissa Shamseer, Douglas G. Altman, et al.. (2012). Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database of Systematic Reviews. 2013(1). MR000030–MR000030. 531 indexed citations breakdown →

2.

Schulz, Hermann, Julia Bohlius, Sven Trelle, et al.. (2007). Immunochemotherapy With Rituximab and Overall Survival in Patients With Indolent or Mantle Cell Lymphoma: A Systematic Review and Meta-analysis. JNCI Journal of the National Cancer Institute. 99(9). 706–714. 268 indexed citations

3.

Schulz, H., Julia Bohlius, Nicole Skoetz, et al.. (2007). Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Database of Systematic Reviews. 2010(1). CD003805–CD003805. 73 indexed citations

4.

Kober, Thilo, et al.. (2006). Fourth Biannual Report of the Cochrane Haematological Malignancies Group. JNCI Journal of the National Cancer Institute. 98(8). E1–E1. 5 indexed citations

5.

Kober, Thilo, Sven Trelle, & Andreas Engert. (2006). Reporting of Randomized Controlled Trials in Hodgkin Lymphoma in Biomedical Journals. JNCI Journal of the National Cancer Institute. 98(9). 620–625. 36 indexed citations

6.

Schulz, H., Julia Bohlius, Nicole Skoetz, et al.. (2006). Combined Immunochemotherapy with Rituximab Improves Overall Survival in Patients with Follicular and Mantle Cell Lymphoma: Updated Meta-Analysis Results.. Blood. 108(11). 2760–2760. 5 indexed citations

7.

Kober, Thilo, Julia Bohlius, Sven Trelle, & Andreas Engert. (2005). Second Biannual Report of the Cochrane Haematological Malignancies Group. JNCI Journal of the National Cancer Institute. 97(7). E1–E. 5 indexed citations

8.

Schulz, H., Nicole Skoetz, Julia Bohlius, et al.. (2005). Does Combined Immunochemotherapy with the Monoclonal Antibody Rituximab Improve Overall Survival in the Treatment of Patients with Indolent Non-Hodgkin Lymphoma? Preliminary Results of a Comprehensive Meta-Analysis.. Blood. 106(11). 351–351. 16 indexed citations

9.

Weingart, Olaf, R. G. H. Baumeister, Klaus Giersiepen, et al.. (2004). [The German Guideline Clearinghouse on Breast Cancer: the need for frequent updating of breast cancer guidelines requires effective guideline updating procedures].. PubMed. 98(5). 403–11. 1 indexed citations

10.

Kober, Thilo, et al.. (2001). . Der Onkologe. 7(9). 1014–1021.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact